Mangoceuticals launches new sildenafil based erectile dysfunction product with signature mango flavor & rapid dissolve

Dallas, texas, aug. 16, 2023 (globe newswire) -- mangoceuticals, inc. (nasdaq:mgrx) (“mangorx” or the “company”), a company focused on developing, marketing, and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ed) drug branded “mango,” today announced the official commercial launch of its second mango ed product, which leverages the company's existing custom compound alongside sildenafil, the active ingredient found in viagra™.
MGRX Ratings Summary
MGRX Quant Ranking